Common GLP-1 Medications Explained Several GLP-1 medications are approved for use in the United States, including: Ozempic (semaglutide) Wegovy (also semaglutide, prescribed for weight management), Trulicity (dulaglutide) Victoza (liraglutide) These are available as weekly or daily injections and have seen a surge in demand, as new studies validate not just their effectiveness for diabetes but also for aiding weight loss
The BMJ report also confirmed that two generic versions of the injectable form of semaglutide were approved by Health Canada in recent weeks, from India's Dr
JAMA 2022;327:534-545
High levels of HO-1 in proximal tubular epithelial cells have been significantly associated with proteinuria, hematuria, and tubulointerstitial disease [257, 260, 261]
Transitioning to SCD can be gradual to allow the body to adapt and to monitor for any adverse reactions
"I use a lot of GLP-1s because they are shown to reduce the risk of dying from heart disease by up to 20% depending on the population